Miller-Fisher syndrome in a patient with rheumatoid arthritis treated with adalimumab

Authors :: Alexander So
Daniel Van Linthoudt
P. T. Kurmann
Source :: Clinical Rheumatology, vol. 28, no. 1, pp. 93-94
Publication Year :: 2009
Abstract: Adalimumab is a frequently prescribed TNFalpha inhibitor for treatment of rheumatoid arthritis. We report on a patient who probably developed a Miller-Fisher syndrome after the second injection of adalimumab.

Subjects :: musculoskeletal diseases
medicine.medical_specialty
Cyclohexanecarboxylic Acids
Antibodies, Monoclonal, Humanized
behavioral disciplines and activities
Arthritis, Rheumatoid
Rheumatology
Internal medicine
Azathioprine
medicine
Adalimumab
Humans
Miller-Fisher syndrome
Amines
skin and connective tissue diseases
Glucocorticoids
gamma-Aminobutyric Acid
Aged
Miller Fisher Syndrome
Dose-Response Relationship, Drug
business.industry
Tumor Necrosis Factor-alpha
Antibodies, Monoclonal
Amines/therapeutic use
Antibodies, Monoclonal/adverse effects
Antirheumatic Agents/adverse effects
Arthritis, Rheumatoid/drug therapy
Azathioprine/therapeutic use
Cyclohexanecarboxylic Acids/therapeutic use
Female
Glucocorticoids/therapeutic use
Miller Fisher Syndrome/etiology
Miller Fisher Syndrome/physiopathology
Treatment Outcome
Tumor Necrosis Factor-alpha/antagonists & inhibitors
gamma-Aminobutyric Acid/therapeutic use
General Medicine
medicine.disease
Dermatology
humanities
Rheumatoid arthritis
Antirheumatic Agents
Tumor necrosis factor alpha
Gabapentin
business
medicine.drug

Tools